Treating adenocarcinoma with bevacizumab

Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland
Treating adenocarcinoma with bevacizumab ( Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland )
15 May 2013

Myc inhibition in pre-clinical mouse models

Dr Laura Soucek - Vall d'Hebron Institute of Oncology
Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )
22 Apr 2013

Closing the cancer divide: Implementing the diagonal approach

Dr Felicia Knaul - Harvard Medical School, Boston, USA
Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )
19 Apr 2013

Utility of robotics in the management of CT detected lung nodules

Giulia Veronesi - European Institute of Oncology, Milan, Italy
Utility of robotics in the management of CT detected lung nodules  ( Giulia Veronesi - European Institute of Oncology, Milan, Italy )
19 Dec 2012

Inequalities in cancer incidence, mortality and survival

Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK
Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )
14 Nov 2012

Influence of cachexia on chemotherapy toxicity

Dr Michael Sawyer – University of Alberta, Canada
Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )
14 Nov 2012

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups
Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012

Chemotherapy and radiotherapy in advanced local non-small cell lung cancer

Dr Dirk De Ruysscher – University of Leuven, Netherlands
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer ( Dr Dirk De Ruysscher – University of Leuven, Netherlands )
12 Oct 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

MET inhibitors for non-small cell lung cancer

Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012